effect of basalt fibres reinforcement and aluminum trihydrate on the thermal properties of intumescent fire retardant coatings

This research is carried out in order to study the synergistic effect of aluminium trihydrate and basalt fibres on the properties of fire resistant intumescent coatings. Intumescent fire retardant coatings were developed using different flame retardants such as ammonium polyphosphate, expandable graphite, melamine and boric acid. These flame retardants were bound together with the help of epoxy binder along with curing agent. Furthermore, individual and combinations of aluminium trihydrate and basalt fibres was incorporated in the formulations to analyse mechanical and chemical properties of the coatings. Char expansion was observed using furnace test, thermogravimetric analysis was used to determine residual weight, X-Ray Diffraction was performed to investigate compounds present in the char, shear test was conducted to determine char strength and scanning electron microscopy analysis was performed to observe morphology of the burnt char. From the microscopic investigation it was concluded that the dense structure of the char increased the char integrity by adding basalt and aluminium trihydrate as fillers. X-Ray Diffraction results shows the presence boron phosphate, and boric acid which enhanced the thermal performance of the coating up to 800°C. From the Thermogravimetric analysis it was concluded that the residual weight of the char was increased up to 34.9 % for IC-B2A4 which enhanced thermal performance of intumescent coating

Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P < 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely

Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56 604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2·5th and 97·5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94·0 deaths (95% UI 89·2-100·0) per 100 000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271·0 deaths [250·1-290·7] per 100 000 population) and Latin America and the Caribbean (195·4 deaths [182·1-211·4] per 100 000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48·1 deaths [47·4-48·8] per 100 000 population) and southeast Asia, east Asia, and Oceania (23·2 deaths [16·3-37·2] per 100 000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1·6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8·3 years (6·7-9·9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0·4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3·6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation

Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

Abstract Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries

Factors Associated with Endodontic Flare-Ups

OBJECTIVE:The objective of the current study was to determine the frequency and factors of endodontic flare-ups and to compare the post obturation pain in single visit and multi visit root canal therapy, at the department of operative dentistry Sardar Begum Dental College (SBDC), Peshawar.MATERIALS AND METHODS:It was a cross sectional study, carried out at the department of operative dentistry, Sardar Begum Dental College, Peshawar. A total sample of 200 subjects was studied. Treatment protocols were standardized and, after taking informed consent endodontic procedure was carried out. Chi-square test was used to explore the relationship between endodontic flare ups with study variables.RESULTS:Our sample consisted of 54% females and 46% males. Frequency of endodontic flare ups was experienced by 48% subjects.96.2% had used antibiotics, Endodontic flare ups was found to be significantly associated with gender, preoperative diagnosis ,preoperative pain and medication while it was not found to be associated with any other variable studied.CONCLUSION:It was concluded that prevalence of post preparation pain during root canal treatment was high and significantly affected by pre-operative pain, preoperative diagnosis and medication. However, careful selection and adherence to the basic principles of endodontic therapy may reduce the occurrence of flare ups

Effect of Withania somnifera leaf extract on the dietary supplementation in transgenic Drosophila model of Parkinson’s disease

The role of Withania somnifera L. leaf extract was studied on the transgenic Drosophila model flies expressing normal human alpha synuclein (h-αS) in the neurons. The leaf extract was prepared in acetone and was subjected to GC-MS analysis. W. somnifera extract at final concentration of 0.25, 0.50 and 1.0 µL/mL was mixed with the diet and the flies were allowed to feed for 24 days. The effect of extract was studied on the climbing ability, lipid peroxidation and protein carbonyl content in the brains of transgenic Drosophila. The exposure of extract to PD model flies did not show any significant delay in the loss of climbing ability nor reduced the oxidative stress in the brains of transgenic Drosophila as compared to untreated PD model flies. The results suggest that W. somnifera leaf extract is not potent in reducing the PD symptoms in transgenic Drosophila model of Parkinson’s disease

Nanorobotics: next level of military technology

Nanorobotics is a scientific discipline gaining in popularity due to the numerous possibilities it provides. Materials science, space exploration, ecology, information technology, electronics, and communications are just a few of the domains where nano-robots can be used. Military weaponry and applications, on the other hand, are being transformed by these new nanorobotics applications. As a result, after a brief introduction to nanoworld theory, the remainder of this article focuses on military applications. The most recent breakthroughs in the military application of nanorobots have been summarised in this report. Military nanotechnologies have been suggested as more devastating weapons than nuclear weapons for the entire planet, with the potential for application in all military locations, due to their fundamentally revolutionary benefits

Synthesis and adsorption behavior of activated carbon impregnated with ASZM-TEDA for purification of contaminated air

In current study, ASZM-TEDA carbon (Carbon impregnated with Copper, Silver, Zinc, Molybdenum and Triethylenediamine) was successfully prepared with non-ammonium water soluble salts using incipient wetness method and TEDA was impregnated on raw activated carbon (RAC) by sublimation process. Aim of this study was to access the adsorption capability of RAC and ASZM-TEDA carbon for SO2 and NO2 gases. For characterization of material, XRD, SEM, EDX spectroscopy, EDX mapping, TGA, BET surface area analyzer and Boehm titrations were used. Results indicate that ASZM-TEDA carbon, prepared with non-ammonium salts, provided satisfactory protection against challenge gases. Using the FTIR based gas analyzer, a significant increase in breakthrough time of ASZM-TEDA carbon was observed i.e. 29.0% for SO2 and 18.7% for NO2 gases as compared to RAC and breakthrough time was 210 and 197 min, respectively. Adsorption capability of ASZM-TEDA carbon was found to be 390 mg NO2/g-C and 448 mg SO2/g-C. In comparison with RAC, ASZM-TEDA carbon showed enhanced adsorption capability up to 31.5% for NO2 and 55.9% for SO2. [Display omitted] •Non-ammonia water soluble salts were used for impregnation.•Metal oxides were impregnated on activated carbon by imbibing limit method.•Triethylenediamine was impregnated on metal impregnated activated carbon surface by sublimation process.•Prepared IACs were found promising and efficient for removal of SO2 and NO2 gases from air.•ASZM-TEDA carbon showed significant decontamination capability for SO2 and NO2 gases